AMYLOID CARDIOMYOPATHY
Clinical trials for AMYLOID CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new AMYLOID CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for AMYLOID CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Breakthrough trial aims to prevent inherited amyloidosis in young adults
Prevention Recruiting nowThis study tests an experimental drug called acoramidis in 587 adults aged 18–75 who carry a faulty gene that causes transthyretin amyloidosis (ATTR) but have no symptoms yet. The drug aims to stabilize a key protein and prevent or delay the buildup of harmful plaques in the hear…
Matched conditions: AMYLOID CARDIOMYOPATHY
Phase: PHASE3 • Sponsor: Eidos Therapeutics, a BridgeBio company • Aim: Prevention
Last updated May 26, 2026 06:47 UTC
-
Heart MRI may unlock secrets of thick heart muscle diseases
Knowledge-focused Recruiting nowThis study uses advanced heart MRI scans to look at blood flow in people with different types of hypertrophic cardiomyopathy (thick heart muscle), including Anderson-Fabry disease and cardiac amyloidosis. Researchers will also study first-degree relatives and genetic carriers. Th…
Matched conditions: AMYLOID CARDIOMYOPATHY
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Knowledge-focused
Last updated May 18, 2026 12:04 UTC